{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:06Z","timestamp":1786115646035,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001857"],"award-info":[{"award-number":["82001857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Hospitals Authority\u2019s Ascent Plan","award":["DFL20241103"],"award-info":[{"award-number":["DFL20241103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"DOI":"10.1007\/s00259-026-08107-7","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T03:47:49Z","timestamp":1785988069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary clinical investigation of 18F-(2S,4R)-4-fluoroglutamine PET\/CT in the evaluation of lung cancer"],"prefix":"10.1007","author":[{"given":"Xiaoxia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"8107_CR1","doi-asserted-by":"publisher","unstructured":"Vanhove K, Derveaux E, Graulus GJ, Mesotten L, Thomeer M, Noben JP, et al. Glutamine Addiction and Therapeutic Strategies in Lung Cancer. Int J Mol Sci. 2019;20. https:\/\/doi.org\/10.3390\/ijms20020252.","DOI":"10.3390\/ijms20020252"},{"key":"8107_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3892\/ol.2023.13745","volume":"25","author":"L Zhou","year":"2023","unstructured":"Zhou L, Zhang Q, Zhu Q, Zhan Y, Li Y, Huang X. Role and therapeutic targeting of glutamine metabolism in non\u2013small cell lung cancer (Review). Oncol Lett. 2023;25:159. https:\/\/doi.org\/10.3892\/ol.2023.13745.","journal-title":"Oncol Lett"},{"key":"8107_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","volume":"3","author":"AA Cluntun","year":"2017","unstructured":"Cluntun AA, Lukey MJ, Cerione RA, Locasale JW Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer. 2017;3:169\u201380. https:\/\/doi.org\/10.1016\/j.trecan.2017.01.005.","journal-title":"Trends Cancer"},{"key":"8107_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","volume":"7","author":"WH Yang","year":"2021","unstructured":"Yang WH, Qiu Y, Stamatatos O, Janowitz T, Lukey MJ. Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy. Trends Cancer. 2021;7:790\u2013804. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.003.","journal-title":"Trends Cancer"},{"key":"8107_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1148\/radiol.2017162610","volume":"287","author":"MPS Dunphy","year":"2018","unstructured":"Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, et al. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of (18)F-(2S,4R)-4-Fluoroglutamine. Radiology. 2018;287:667\u201375. https:\/\/doi.org\/10.1148\/radiol.2017162610.","journal-title":"Radiology"},{"key":"8107_CR6","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2967\/jnumed.111.093815","volume":"52","author":"BP Lieberman","year":"2011","unstructured":"Lieberman BP, Ploessl K, Wang L, Qu W, Zha Z, Wise DR, et al. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine. J Nucl Med. 2011;52:1947\u201355. https:\/\/doi.org\/10.2967\/jnumed.111.093815.","journal-title":"J Nucl Med"},{"key":"8107_CR7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.111.101279","volume":"53","author":"K Ploessl","year":"2012","unstructured":"Ploessl K, Wang L, Lieberman BP, Qu W, Kung HF. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents. J Nucl Med. 2012;53:1616\u201324. https:\/\/doi.org\/10.2967\/jnumed.111.101279.","journal-title":"J Nucl Med"},{"key":"8107_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1021\/ja109203d","volume":"133","author":"W Qu","year":"2011","unstructured":"Qu W, Zha Z, Ploessl K, Lieberman BP, Zhu L, Wise DR, et al. Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors. J Am Chem Soc. 2011;133:1122\u201333. https:\/\/doi.org\/10.1021\/ja109203d.","journal-title":"J Am Chem Soc"},{"key":"8107_CR9","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s00259-019-04543-w","volume":"47","author":"X Xu","year":"2020","unstructured":"Xu X, Zhu H, Liu F, Zhang Y, Yang J, Zhang L, et al. Dynamic PET\/CT imaging of (18)F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients. Eur J Nucl Med Mol Imaging. 2020;47:2280\u201392. https:\/\/doi.org\/10.1007\/s00259-019-04543-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8107_CR10","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1097\/RLU.0000000000002257","volume":"43","author":"X Xu","year":"2018","unstructured":"Xu X, Zhu H, Liu F, Zhang Y, Yang J, Zhang L, et al. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine. Clin Nucl Med. 2018;43:e392\u20139. https:\/\/doi.org\/10.1097\/RLU.0000000000002257.","journal-title":"Clin Nucl Med"},{"key":"8107_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00259-024-06976-4","volume":"52","author":"H Yuan","year":"2025","unstructured":"Yuan H, Chen X, Zhao X, Dai M, Liu Y, Han J, et al. A head-to-head comparison of [(68)Ga]Ga-DOTA-FGFR1 and [(18)F]FDG PET\/CT in the diagnosis of lung cancer. Eur J Nucl Med Mol Imaging. 2025;52:979\u201392. https:\/\/doi.org\/10.1007\/s00259-024-06976-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8107_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2967\/jnumed.116.179739","volume":"58","author":"X Li","year":"2017","unstructured":"Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, et al. Semiquantitative Parameters in PSMA-Targeted PET Imaging with (18)F-DCFPyL: Variability in Normal-Organ Uptake. J Nucl Med. 2017;58:942\u20136. https:\/\/doi.org\/10.2967\/jnumed.116.179739.","journal-title":"J Nucl Med"},{"key":"8107_CR13","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00259-022-05818-5","volume":"49","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang S, Xu X, Meng X, Zhang H, Zhang A, et al. Higher accuracy of [(68) Ga]Ga-DOTA-FAPI-04 PET\/CT comparing with 2-[(18)F]FDG PET\/CT in clinical staging of NSCLC. Eur J Nucl Med Mol Imaging. 2022;49:2983\u201393. https:\/\/doi.org\/10.1007\/s00259-022-05818-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8107_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"8107_CR15","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","volume":"18","author":"TW Meijer","year":"2012","unstructured":"Meijer TW, Kaanders JH, Span PN, Bussink J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin Cancer Res. 2012;18:5585\u201394. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0858.","journal-title":"Clin Cancer Res"},{"key":"8107_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","volume":"23","author":"SM Davidson","year":"2016","unstructured":"Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA, Luengo A, et al. Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metab. 2016;23:517\u201328. https:\/\/doi.org\/10.1016\/j.cmet.2016.01.007.","journal-title":"Cell Metab"},{"key":"8107_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/PPO.0000000000000716","volume":"30","author":"AR Pantel","year":"2024","unstructured":"Pantel AR, Bae SW, Li EJ, O\u2019Brien SR, Manning HC. PET Imaging of Metabolism, Perfusion, and Hypoxia: FDG and Beyond. Cancer J. 2024;30:159\u201369. https:\/\/doi.org\/10.1097\/PPO.0000000000000716.","journal-title":"Cancer J"},{"key":"8107_CR18","doi-asserted-by":"publisher","first-page":"5185951","DOI":"10.1155\/2022\/5185951","volume":"2022","author":"Y Seo","year":"2022","unstructured":"Seo Y, Craig MC, Murphy ST, Feng J, Chen X, Yuneva M. [(18)F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC). Mol Imaging. 2022;2022:5185951. https:\/\/doi.org\/10.1155\/2022\/5185951.","journal-title":"Mol Imaging"},{"key":"8107_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell. 2009;136:521\u201334. https:\/\/doi.org\/10.1016\/j.cell.2008.11.044.","journal-title":"Cell"},{"key":"8107_CR20","doi-asserted-by":"publisher","first-page":"624324","DOI":"10.3389\/fimmu.2021.624324","volume":"12","author":"M Nachef","year":"2021","unstructured":"Nachef M, Ali AK, Almutairi SM, Lee SH. Targeting SLC1A5 and SLC3A2\/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment. Front Immunol. 2021;12:624324. https:\/\/doi.org\/10.3389\/fimmu.2021.624324.","journal-title":"Front Immunol"},{"key":"8107_CR21","doi-asserted-by":"publisher","unstructured":"Liu YH, Li YL, Shen HT, Chien PJ, Sheu GT, Wang BY, et al. L-Type Amino Acid Transporter 1 Regulates Cancer Stemness and the Expression of Programmed Cell Death 1 Ligand 1 in Lung Cancer Cells. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms222010955.","DOI":"10.3390\/ijms222010955"},{"key":"8107_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiol.12120254","volume":"266","author":"F Ng","year":"2013","unstructured":"Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology. 2013;266:177\u201384. https:\/\/doi.org\/10.1148\/radiol.12120254.","journal-title":"Radiology"},{"key":"8107_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1102\/1470-7330.2010.0021","volume":"10","author":"B Ganeshan","year":"2010","unstructured":"Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA. Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging. 2010;10:137\u201343. https:\/\/doi.org\/10.1102\/1470-7330.2010.0021.","journal-title":"Cancer Imaging"},{"key":"8107_CR24","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1080\/15548627.2021.2008690","volume":"18","author":"TG Keulers","year":"2022","unstructured":"Keulers TG, Koch A, van Gisbergen MW, Barbeau LMO, Zonneveld MI, de Jong MC, et al. ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer. Autophagy. 2022;18:1898\u2013914. https:\/\/doi.org\/10.1080\/15548627.2021.2008690.","journal-title":"Autophagy"},{"key":"8107_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2011","unstructured":"Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature. 2011;481:380\u20134. https:\/\/doi.org\/10.1038\/nature10602.","journal-title":"Nature"},{"key":"8107_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41467-018-08033-9","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Bai C, Ruan Y, Liu M, Chu Q, Qiu L, et al. Coordinative metabolism of glutamine carbon and nitrogen in proliferating cancer cells under hypoxia. Nat Commun. 2019;10:201. https:\/\/doi.org\/10.1038\/s41467-018-08033-9.","journal-title":"Nat Commun"},{"key":"8107_CR27","doi-asserted-by":"publisher","first-page":"e10250","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016;5:e10250. https:\/\/doi.org\/10.7554\/eLife.10250.","journal-title":"Elife"},{"key":"8107_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13045-022-01359-4","volume":"15","author":"T Liu","year":"2022","unstructured":"Liu T, Han C, Fang P, Ma Z, Wang X, Chen H, et al. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma. J Hematol Oncol. 2022;15:141. https:\/\/doi.org\/10.1186\/s13045-022-01359-4.","journal-title":"J Hematol Oncol"},{"key":"8107_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lungcan.2007.08.036","volume":"60","author":"N Al-Sarraf","year":"2008","unstructured":"Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V. Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. Lung Cancer. 2008;60:62\u20138. https:\/\/doi.org\/10.1016\/j.lungcan.2007.08.036.","journal-title":"Lung Cancer"},{"key":"8107_CR30","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41591-025-03633-7","volume":"31","author":"NL Albert","year":"2025","unstructured":"Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, et al. RANO criteria for response assessment of brain metastases based on amino acid PET imaging. Nat Med. 2025;31:1424\u201330. https:\/\/doi.org\/10.1038\/s41591-025-03633-7.","journal-title":"Nat Med"},{"key":"8107_CR31","doi-asserted-by":"publisher","first-page":"145419","DOI":"10.1016\/j.gene.2021.145419","volume":"775","author":"M Tandon","year":"2021","unstructured":"Tandon M, Othman AH, Winogradzki M, Pratap J. Bone metastatic breast cancer cells display downregulation of PKC-zeta with enhanced glutamine metabolism. Gene. 2021;775:145419. https:\/\/doi.org\/10.1016\/j.gene.2021.145419.","journal-title":"Gene"},{"key":"8107_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","volume":"22","author":"F Dupuy","year":"2015","unstructured":"Dupuy F, Tabaries S, Andrzejewski S, Dong Z, Blagih J, Annis MG, et al. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer. Cell Metab. 2015;22:577\u201389. https:\/\/doi.org\/10.1016\/j.cmet.2015.08.007.","journal-title":"Cell Metab"},{"key":"8107_CR33","doi-asserted-by":"publisher","first-page":"19611","DOI":"10.1073\/pnas.1117773108","volume":"108","author":"DR Wise","year":"2011","unstructured":"Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A. 2011;108:19611\u20136. https:\/\/doi.org\/10.1073\/pnas.1117773108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8107_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/RLU.0000000000005581","volume":"50","author":"X Xu","year":"2025","unstructured":"Xu X, Zhao H, Liu F, Xie Q, Yang J, Li S, et al. Clinical Value of 18 F-(2S,4R)-4-Fluoroglutamine PET\/CT in Glioma. Clin Nucl Med. 2025;50:125\u201332. https:\/\/doi.org\/10.1097\/RLU.0000000000005581.","journal-title":"Clin Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08107-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T03:47:50Z","timestamp":1785988070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08107-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":34,"alternative-id":["8107"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08107-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the Medical Ethics Committee of Peking University Cancer Hospital (2017KT38).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}